Literature DB >> 19463479

HBV infection in indigenous children, 20 years after immunization in Taiwan: a community-based study.

Chung-Feng Huang1, Chia-Yen Dai, Wan-Long Chuang, Chi-Kung Ho, Ta-Chung Wu, Nai-Jen Hou, Chao-Ling Wang, Ming-Yen Hsieh, Jee-Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Jun-Fa Tsai, Wen-Yu Chang, Ming-Lung Yu.   

Abstract

OBJECTIVES: Hepatitis B virus infection is hyperendemic in Taiwan. In the past, the infection rate has been higher in indigenous villages. The prevalence of chronic HBV infection among indigenous children after immunization remains unknown.
METHODS: A total of 843 indigenous children were checked for the hepatitis B seromarker. Another 606 metropolitan children were enrolled for comparison in 2005.
RESULTS: The seroprevalences (%) of HBsAg, (hepatitis B surface antigen) anti-HBs, (antibody to hepatitis B surface antigen) and anti-HBc (antibody to hepatitis B core antigen) among indigenous and metropolitan children were 3.2 vs. 0.17 (p<0.001), 47.4 vs. 51.2 (p=0.164), and 10.7 vs. 1.7 (p<0.001), respectively. Among the indigenous children, who were divided into three age groups, the prevalences of HBsAg and anti-HBc increased with age, while anti-HBs decreased significantly (p=0.025, 0.002, and <0.001, respectively). Children with positive HBsAg had a significantly higher mean (SD) age (10.2 (2.2) vs. 9.2 (2.1) years, p=0.024) and a higher ALT value (16.4 (8.0) vs. 10.6 (8.3) IU/L, p=0.001). In a multivariable analysis, indigenous residency, older age group and abnormal ALT value were independent factors associated with positive HBsAg.
CONCLUSIONS: The seroprevalence of hepatitis B infection has obviously declined among indigenous children 20 years after mass immunization programs launched in Taiwan. However, it is still higher than that of metropolitan children. Higher rates of chronic HBV infection in the mothers might be one important explanation for this finding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463479     DOI: 10.1016/j.ypmed.2009.02.002

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  5 in total

Review 1.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

2.  Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patients.

Authors:  Jer-Ming Chang; Chung-Feng Huang; Szu-Chia Chen; Chia-Yen Dai; Ming-Lun Yeh; Jee-Fu Huang; Hsing-Tao Kuo; Wan-Long Chuang; Ming-Lung Yu; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Int J Med Sci       Date:  2014-03-08       Impact factor: 3.738

3.  Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.

Authors:  Tyng-Yuan Jang; Pei-Chin Lin; Ching-I Huang; Yu-Mei Liao; Ming-Lun Yeh; Yu-Sheng Zeng; Po-Cheng Liang; Wan-Yi Hsu; Shih-Pien Tsai; Zu-Yau Lin; Shinn-Cherng Chen; Jee-Fu Huang; Chia-Yen Dai; Chung-Feng Huang; Shyh-Shin Chiou; Wan-Long Chuang; Ming-Lung Yu
Journal:  PLoS One       Date:  2017-06-09       Impact factor: 3.240

Review 4.  The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis.

Authors:  Min Deng; Xin Zhou; Sheng Gao; Shi-Gui Yang; Bing Wang; Hua-Zhong Chen; Bing Ruan
Journal:  Virol J       Date:  2012-09-04       Impact factor: 4.099

5.  Hepatitis B Seroprotection and the Response to a Challenging Dose among Vaccinated Children in Red Sea Governorate.

Authors:  Samia M Sami; Iman I Salama; Ghada A Abdel-Latif; Lobna A El Etreby; Ahmed I Metwally; Naglaa F Abd El Haliem
Journal:  Open Access Maced J Med Sci       Date:  2016-05-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.